🔥🐔 BizChicken 🐔🔥

Companies Similar to INVO Bioscience, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

ImmunityBio, Inc.

ImmunityBio, Inc. logo
Market Cap: High
Employees: Medium

Therapies and Vaccines

Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.

Tags: biotechnology, cancer, cell therapy, immunotherapy, infectious diseases, vaccines

Symbol: IBRX

Recent Price: $2.68

Industry: Biotechnology

CEO: Mr. Richard Gerald Adcock

Sector: Healthcare

Employees: 622

Address: 3530 John Hopkins Court, San Diego, CA 92121

Phone: 858 633 0300

Last updated: 2024-12-31

INmune Bio, Inc.

INmune Bio, Inc. logo
Market Cap: Low
Employees: Lowest

INKmune

INmune Bio, Inc. is a clinical-stage immunotherapy company focused on developing drugs to reprogram the patient's innate immune system for the treatment of hematologic malignancies, solid tumors, chronic inflammation, and Alzheimer's disease.

Tags: Alzheimer's disease, chronic inflammation, hematologic malignancies, immunotherapy, solid tumors

Symbol: INMB

Recent Price: $4.65

Industry: Biotechnology

CEO: Dr. Raymond Joseph Tesi M.D.

Sector: Healthcare

Employees: 11

Address: 225 NE Mizner Boulevard, Boca Raton, FL 33432

Phone: 858 964 3720

Last updated: 2024-12-31

Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc. logo
Market Cap: Low
Employees: Low

Therapeutic Candidates (INBRX-109, INBRX-106)

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops biologic therapeutics for life-threatening conditions, with therapeutic candidates in phase 2 clinical trials targeting various cancers.

Tags: biologic therapeutics, biopharmaceutical, cancer treatment, clinical-stage

Symbol: INBX

Recent Price: $15.14

Industry: Biotechnology

CEO: Mr. Mark Paul Lappe

Sector: Healthcare

Employees: 166

Address: 11025 North Torrey Pines Road, La Jolla, CA 92037

Phone: 858-795-4220

Last updated: 2024-12-31

Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. logo
Market Cap: Highest
Employees: Medium

INGREZZA

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for various conditions, focusing on innovative solutions for unmet medical needs.

Tags: Parkinson's disease, endocrine disorders, endometriosis, neurology, pharmaceuticals, psychiatric disorders, tardive dyskinesia, uterine fibroids

Symbol: NBIX

Recent Price: $137.06

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Kyle W. Gano Ph.D.

Sector: Healthcare

Employees: 1700

Address: 12780 El Camino Real, San Diego, CA 92130

Phone: 858 617 7600

Last updated: 2024-12-31

Enzo Biochem, Inc.

Enzo Biochem, Inc. logo
Market Cap: Lowest
Employees: Low

Life Sciences Products

Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company specializing in the research, development, manufacture, and marketing of diagnostic and research products using genetic engineering, biotechnology, and molecular biology. It operates through segments focused on Life Sciences Products, Clinical Laboratory Services, and Therapeutics.

Tags: Biotechnology, Clinical Laboratory, Diagnostics, Genetic Engineering, Life Sciences, Molecular Biology

Symbol: ENZ

Recent Price: $0.70

Industry: Medical - Diagnostics & Research

CEO: Ms. Kara Cannon

Sector: Healthcare

Employees: 125

Address: 527 Madison Avenue, New York, NY 10022

Phone: 212 583 0100

Last updated: 2024-12-31

BioVie Inc.

BioVie Inc. logo
Market Cap: Lowest
Employees: Lowest

BIV201, NE3107

Bio Vie Inc., a clinical stage biotechnology company, focuses on discovering, developing, and commercializing drug therapies in the United States, with products targeting liver cirrhosis, Alzheimer's, Parkinson's, multiple myeloma, and prostate cancer.

Tags: Alzheimer's, Biotechnology, Clinical Trials, Drug Development, Liver Cirrhosis, Parkinson's, Pharmaceutical

Symbol: BIVI

Recent Price: $2.09

Industry: Biotechnology

CEO: Mr. Cuong Viet Do M.B.A.

Sector: Healthcare

Employees: 14

Address: 680 West Nye Lane, Carson City, NV 89703

Phone: 775 888 3162

Last updated: 2024-12-31

Celularity Inc.

Celularity Inc. logo
Market Cap: Lowest
Employees: Low

CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.

Tags: biotechnology, cancer, cell therapies, immune diseases, infectious diseases, placental-derived

Symbol: CELU

Recent Price: $2.05

Industry: Biotechnology

CEO: Dr. Robert Joseph Hariri M.D., Ph.D.

Sector: Healthcare

Employees: 120

Address: 170 Park Avenue, Florham Park, NJ 07932

Phone: 908 768 2170

Leadership

  • Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
  • David Beers, CFA, Chief Financial Officer
  • Stephen Brigido, DPM, President, Degenerative Diseases
  • John Haines, Global Manager and Chief Administrative Officer
  • K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
  • John Colerangle, DVM, Ph.D., Regulatory Affairs
  • Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
  • Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
  • Carmine Palummo, Corporate Operations
  • Tim Wilk, Technical Operations
  • Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
  • Peter Diamandis, M.D., Director
  • Dean Kehler, Director
  • Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
  • Diane Parks, Director

Last updated: 2024-12-31

Harvard Bioscience, Inc.

Harvard Bioscience, Inc. logo
Market Cap: Low
Employees: Medium

cellular and molecular technology instruments

Harvard Bioscience, Inc. develops, manufactures, and sells technologies and services that support research, discovery, and pre-clinical testing for drug development globally, offering a wide range of instruments for tissue and organ-based lab research.

Tags: biotech, drug development, laboratory instruments, precision measuring, research

Symbol: HBIO

Recent Price: $2.02

Industry: Medical - Instruments & Supplies

CEO: Mr. James W. Green

Sector: Healthcare

Employees: 391

Address: 84 October Hill Road, Holliston, MA 01746

Phone: 508 893 8999

Leadership

  • James Green, Chairman, President & Chief Executive Officer
  • Jennifer Cote, Chief Financial Officer and Treasurer
  • John Fry, Chief Legal Counsel and Corporation Secretary
  • Diane Houston, Vice President, Global IT
  • Lori Packer, Vice President, Global People Operations
  • Nitya Shetty, Vice President, Global Research and Development
  • Ryan Wallace, Senior Vice President, Global Sales

Last updated: 2024-12-31

Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Low

DNA Medicines

Inovio Pharmaceuticals is a biotechnology company focused on discovering, developing, and commercializing DNA medicines to treat and protect against diseases like HPV, cancer, and infectious diseases. Their platform includes Syn Con designed DNA sequences and CELLECTRA smart devices technology for delivery.

Tags: DNA medicines, HPV, biotechnology, cancer, clinical studies, infectious diseases

Symbol: INO

Recent Price: $1.78

Industry: Biotechnology

CEO: Dr. Jacqueline E. Shea Ph.D.

Sector: Healthcare

Employees: 127

Address: 660 West Germantown Pike, Plymouth Meeting, PA 19462

Phone: 267 440 4200

Leadership

  • Jacqueline Shea, Ph.D., President & Chief Executive Officer
  • Peter Kies, Chief Financial Officer
  • Michael Sumner, MB BS, MBA, Chief Medical Officer
  • Laurent Humeau, Ph.D., Chief Scientific Officer; Chairman, Scientific Advisory Board
  • Steve Egge, MBA, Chief Commercial Officer
  • Rob Crotty, J.D., General Counsel and Chief Compliance Officer
  • EJ Brandreth, MBA, Senior Vice President, Quality Assurance
  • Shawn Bridy, MA, MBA, Senior Vice President, Business Development
  • Cheryl Elder, PharmD, Senior Vice President, Regulatory Affairs
  • Robert J. Juba Jr., Senior Vice President, Biological Manufacturing and Clinical Supply Management
  • Jeffrey Skolnik, M.D., Senior Vice President, Clinical Development
  • Dave Liebowitz, M.D. & Ph.D., Senior Vice President, Early-Stage Clinical Development
  • Simon X. Benito, Chairman of the Board, Inovio Pharmaceuticals
  • Roger D. Dansey, M.D., Chief Medical Officer at Seagen
  • Ann C. Miller, M.D., Former Head of Sanofi Oncology Global Marketing
  • Jay Shepard, Former President & CEO of Aravive
  • David B. Weiner, Ph.D., Executive Vice President, Director, Vaccine Center, The Wistar Institute
  • Wendy L. Yarno, MBA, Former Executive Vice President and Chief Marketing Officer at Merck & Co., Inc.
  • Lota S. Zoth, CPA, Former Chief Financial Officer, MedImmune
  • Rafi Ahmed, Ph.D., Director, Emory Vaccine Center, Emory University School of Medicine
  • Stanley A. Plotkin, M.D., Emeritus Professor, Wistar Institute and University of Pennsylvania; Principal, Vaxconsult

Last updated: 2024-12-31

INVO Bioscience, Inc.

INVO Bioscience, Inc. logo
Market Cap: Lowest
Employees: Lowest

INVOcell

INVO Bioscience, Inc. is a fertility company providing assisted reproductive technology solutions with its flagship product, INVOcell, promoting in vivo fertilization and early embryo development. The company aims to make fertility care more accessible worldwide.

Tags: Fertility, Healthcare, INVOcell, Medical Device, Reproductive Technology

Symbol: INVO

Recent Price: $0.83

Industry: Medical - Devices

CEO: Mr. Steven M. Shum

Sector: Healthcare

Employees: 25

Address: 5582 Broadcast Court, Sarasota, FL 34240

Phone: 978 878 9505

Last updated: 2024-12-31

Inozyme Pharma, Inc.

Inozyme Pharma, Inc. logo
Market Cap: Medium
Employees: Lowest

INZ-701

Inozyme Pharma, Inc. is a biopharmaceutical company focused on the development of therapeutics for rare disease conditions involving abnormal mineralization, particularly targeting ENPP1 and ABCC6 deficiencies.

Tags: ABCC6, ENPP1, INZ-701, biopharmaceutical, calciphylaxis, genetic diseases, mineralization, rare diseases, therapeutics

Symbol: INZY

Recent Price: $2.82

Industry: Biotechnology

CEO: Dr. Douglas A. Treco Ph.D.

Sector: Healthcare

Employees: 59

Address: 321 Summer Street, Boston, MA 02210

Phone: 857 330 4340

Leadership

  • Doug Treco, Ph.D., CEO, Chairman of Board of Directors
  • Gayle Gironda, Senior Vice President and Chief People Officer
  • Kurt Gunter, M.D., Senior Vice President and Chief Medical Officer
  • Soojin Kim, Ph.D., Senior Vice President and Chief Technical Operations Officer
  • Yves Sabbagh, Ph.D., Senior Vice President and Chief Scientific Officer, Chair of the Scientific Advisory Board
  • Sanjay S. Subramanian, M.S., MBA, Senior Vice President and Chief Financial Officer
  • Matt Winton, Ph.D., Senior Vice President and Chief Operating Officer
  • Axel Bolte, MBA, Co-founder, Senior Advisor and Member of Board of Directors
  • David Thompson, M.A., M.S., Ph.D., Senior Advisor, Member of Scientific Advisory Board
  • Sarah Bhagat, Ph.D., Director
  • Reinaldo M. Diaz, MBA, Director
  • Martin Edwards M.D., MBA, Director
  • Erik Harris, MBA, Director
  • Rob Hopfner, Rph, Ph.D., MBA, Director
  • Edward Mathers, Director
  • Lynne Sullivan, MST, Director

Last updated: 2024-12-31

Organovo Holdings, Inc.

Organovo Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

Novo Gen Bioprinters

Organovo Holdings, Inc. is a biotechnology company that develops 3D tissues to model human diseases, utilizing proprietary bioprinting technologies such as Novo Gen Bioprinters for fabricating living tissues.

Tags: 3D tissues, Ex Vive, Novo Gen Bioprinters, bioprinting, biotechnology, human disease

Symbol: ONVO

Recent Price: $0.36

Industry: Biotechnology

CEO: Mr. Keith E. Murphy

Sector: Healthcare

Employees: 20

Address: 11555 Sorrento Valley Road, Solana Beach, CA 92121

Phone: 858 224 1000

Leadership

  • Keith Murphy, Executive Chairman, CEO
  • Thomas P. Hess, Chief Financial Officer
  • Curtis Tyree, Ph.D., Senior Vice President, Strategy and Business Development
  • Adam K. Stern, CEO
  • Alison Milhous, Vice President, Accounting
  • David Gobel, CEO
  • Doug Cohen, President and Chief Executive Officer
  • Vaidehi Joshi, Director of Discovery Biology

Last updated: 2024-12-31

Renovaro Biosciences Inc.

Renovaro Biosciences Inc. logo
Market Cap: Lowest
Employees: Lowest

RENB-HV-01, RENB-HV-12, RENB-HB-01, RENB-DC-11, RENB-DC-12-XX, RENB-HV-21

Renovaro Biosciences Inc. is a pre-clinical stage biotechnology company focused on R&D of pharmaceutical and biological products for treating HIV, HBV, and cancer in the U.S. The company has a robust product pipeline and strategic partnerships, and was formerly known as Enochian Biosciences, Inc.

Tags: HBV treatment, HIV treatment, biotechnology, cancer treatment, pharmaceutical research, strategic partnerships

Symbol: RENB

Recent Price: $0.87

Industry: Biotechnology

CEO: Mr. David H. Weinstein

Sector: Healthcare

Employees: 25

Address: 2080 Century Park East, Los Angeles, CA 90067

Phone: 305 918 1980

Last updated: 2024-12-31

Sana Biotechnology, Inc.

Sana Biotechnology, Inc. logo
Market Cap: Medium
Employees: Medium

N/A

Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines, developing cell engineering platforms for various therapeutic areas including oncology, diabetes, and genetic disorders.

Tags: biotechnology, cell engineering, genetic disorders, medicine, oncology

Symbol: SANA

Recent Price: $1.61

Industry: Biotechnology

CEO: Dr. Steven D. Harr M.D.

Sector: Healthcare

Employees: 328

Address: 188 East Blaine Street, Seattle, WA 98102

Phone: 206 701 7914

Last updated: 2024-12-31

Instil Bio, Inc.

Instil Bio, Inc. logo
Market Cap: Low
Employees: Lowest

ITIL-168, ITIL-306

Instil Bio, Inc. is a clinical-stage biopharmaceutical company that develops cell therapies for treating cancer patients, focusing on autologous tumor infiltrating lymphocyte (TIL) treatments.

Tags: TIL, biopharmaceutical, cancer therapy, cell therapy, clinical-stage

Symbol: TIL

Recent Price: $18.99

Industry: Biotechnology

CEO: Mr. Bronson Crouch

Sector: Healthcare

Employees: 49

Address: 3963 Maple Avenue, Dallas, TX 75219

Phone: 972 499 3350

Last updated: 2024-12-31

ZIVO Bioscience, Inc.

ZIVO Bioscience, Inc. logo
Market Cap: Lowest
Employees: Lowest

natural bioactive ingredients

ZIVO Bioscience, Inc. is a research and development company specializing in licensing and selling natural bioactive ingredients derived from proprietary algae cultures, serving the biotech and agtech sectors with intellectual property in human and animal health applications.

Tags: agtech, algae cultures, animal health, biotech, human health, intellectual property, natural bioactive ingredients

Symbol: ZIVO

Recent Price: $20.89

Industry: Biotechnology

CEO: Mr. John B. Payne

Sector: Healthcare

Employees: 8

Address: 21 East Long Lake Road, Bloomfield Hills, MI 48304

Phone: 248 452 9866

Leadership

  • John B. Payne, President / Chief Executive Officer / Chairman of the Board
  • Keith Marchiando, Chief Financial Officer
  • William P. Pfund, Vice-President, Research & Development
  • Dr. Amy Steffek, Director, Research & Development
  • Dr. Harlan L. Miller III, Vice-President of Technology and Global Supply
  • Dr. Laura Belicka, Senior Scientist
  • Amy Elizabeth Steffek, Director of Research & Development
  • Alison A. Cornell, Executive Vice President & Chief Financial Officer
  • Christopher Maggiore, Director
  • Nola E. Masterson, Director
  • Laith Yaldoo, Director

Last updated: 2024-12-31

Enovix Corporation

Enovix Corporation logo
Market Cap: High
Employees: Medium

Enovix Batteries

Enovix Corporation designs, develops, and manufactures advanced lithium-ion batteries, providing enhanced performance and technology solutions for various applications.

Tags: Battery Technology, Electric Vehicles, Laptops, Lithium-Ion Batteries, Smartphones, Wearables

Symbol: ENVX

Recent Price: $11.00

Industry: Electrical Equipment & Parts

CEO: Dr. Raj Talluri

Sector: Industrials

Employees: 560

Address: 3501 West Warren Avenue, Fremont, CA 94538

Phone: 510 695 2350

Last updated: 2024-12-31

Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

Imm Celz

Creative Medical Technology Holdings, Inc. is a biotechnology company focusing on using adult stem cell treatments for immunology, urology, orthopedics, and neurology, offering solutions like Caver Stem, Fem Celz, Stem Spine, Imm Celz, and Ova Stem.

Tags: biotechnology, immunology, neurology, orthopedics, stem cell treatments, urology

Symbol: CELZ

Recent Price: $2.34

Industry: Biotechnology

CEO: Mr. Timothy Warbington

Sector: Healthcare

Employees: 4

Address: 211 East Osborn Road, Phoenix, AZ 85012

Phone: 480 399 2822

Last updated: 2024-12-31

BioLife Solutions, Inc.

BioLife Solutions, Inc. logo
Market Cap: Medium
Employees: Medium

bioproduction tools and services

Bio Life Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services essential for the cell and gene therapy industry globally. The company's offerings include biopreservation media products, automated thawing products, cloud-connected shipping containers, and storage solutions for biologics and pharmaceuticals.

Tags: biological storage, biologics, biopreservation, cell therapy, cryogenic equipment, gene therapy, pharmaceuticals, temperature-sensitive storage

Symbol: BLFS

Recent Price: $26.27

Industry: Medical - Instruments & Supplies

CEO: Mr. Roderick de Greef

Sector: Healthcare

Employees: 409

Address: 3303 Monte Villa Parkway, Bothell, WA 98021

Phone: 425 402 1400

Leadership

  • Rod de Greef, Chairman & Chief Executive Officer
  • Aby J. Mathew, Ph.D., Executive Vice President and Chief Scientific Officer
  • Karen Foster, Chief Quality and Operations Officer
  • Troy Wichterman, Chief Financial Officer
  • Todd Berard, Chief Marketing Officer
  • Garrie Richardson, Chief Revenue Officer
  • Sarah Aebersold, Chief Human Resources Officer
  • Mike Pallotta, Global VP, Hardware and Electrical Engineering
  • Brett Stucker, VP of Cybersecurity and Information Security Officer
  • Amy DuRoss,
  • Rachel Ellingson,
  • Joydeep Goswami, MBA, Ph.D.,
  • Tim Moore,
  • Joseph Schick, Chairman – Audit Committee
  • Andrew Hinson,
  • Anthony Davies, Ph.D.,
  • Colleen Delaney, M.D., M.Sc.,
  • Dayong Gao, Ph.D.,
  • Erik Woods, Ph.D., HCLD(ABB),
  • Jon Rowley, Ph.D.,
  • John McMannis, Ph.D.,
  • Jerry E. Cooley, M.D.,
  • Jason Acker, MBA, Ph.D.,
  • Lizabeth Cardwell, MT (ASCP), MBA, RAC,
  • Scott R. Burger, M.D.,
  • Shelly Heimfeld, Ph.D.,

Last updated: 2024-12-31

IN8bio, Inc.

IN8bio, Inc. logo
Market Cap: Lowest
Employees: Lowest

INB-200, INB-100, INB-400, INB-300

IN8bio, Inc. is a clinical-stage biotechnology company focused on gamma-delta T cell therapies for cancer treatment, with lead products in clinical trials and preclinical development.

Tags: biopharmaceutical, biotechnology, cancer treatment, clinical trials, gamma-delta T cell therapies

Symbol: INAB

Recent Price: $0.27

Industry: Biotechnology

CEO: Mr. Tai-Wei Ho

Sector: Healthcare

Employees: 39

Address: 350 5th Avenue, New York, NY 10118

Phone: 646 600 6438

Last updated: 2024-12-31